Abiopharma

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Hyphens Notification - PhillipCapitals Equity Research - Bump in the Road, Scaling Up Journey Intact

Dizon Romeo R 🟢 acquired 1.0K shares of IRIDEX CORP (IRIX) at $1.36 Transaction Date: Aug 28, 2025 | Filing ID: 112112

Director Ruemler Timothy James 🔴 sold 20.0K shares of Sharps Technology Inc. (STSS) at $17.09 Transaction Date: Aug 27, 2025 | Filing ID: 025871

Director Szot Matthew K 🟢 acquired 45.0K shares (1 derivative) of INVO Fertility, Inc. (IVF) at $1.01 Transaction Date: Aug 26, 2025 | Filing ID: 025869

Goren Andrea 🟢 acquired 50.0K shares (1 derivative) of INVO Fertility, Inc. (IVF) at $1.01 Transaction Date: Aug 26, 2025 | Filing ID: 025866

Decheng Capital China Life Sciences USD Fund III, L.P. 🔴 sold 4.1K shares of BeyondSpring Inc. (BYSI) at $1.81 Transaction Date: Aug 26, 2025 | Filing ID: 023258

REPL Class Action Reminder: Investors with Large Losses Should Contact Robbins LLP for Information About the Pending Lead Plaintiff Deadline in the Replimune Group, Inc. Class Action Lawsuit

Director Gibson Christopher 🟡 adjusted position in 536.0K shares (10 derivative) of RECURSION PHARMACEUTICALS, INC. (RXRX) at $11.40 Transaction Date: Aug 26, 2025 | Filing ID: 000136

Alterity Therapeutics - Annual Report FY25

New Form 3 - ZYNEX INC Filed: 2025-08-28 AccNo: 0001415889-25-023253 Size: 3 KB

New Form 3/A - Inhibikase Therapeutics, Inc. Filed: 2025-08-28 AccNo: 0001193125-25-191465 Size: 5 KB

New Form 3/A - Inhibikase Therapeutics, Inc. Filed: 2025-08-28 AccNo: 0001193125-25-191464 Size: 5 KB

Munshi Amit 🟢 acquired 57.3K shares of Inhibikase Therapeutics, Inc. (IKT) Transaction Date: Feb 21, 2025 | Filing ID: 191463

Morrison Jodie Pope 🔴 sold 10.5K shares of Q32 Bio Inc. (QTTB) at $1.80 Transaction Date: Aug 26, 2025 | Filing ID: 191452